TY - JOUR
T1 - Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study
AU - Hastie, Claire E
AU - Lowe, David J
AU - McAuley, Andrew
AU - Winter, Andrew J
AU - Mills, Nicholas L
AU - Black, Corri
AU - Scott, Janet T
AU - O'Donnell, Catherine A
AU - Blane, David N
AU - Browne, Susan
AU - Ibbotson, Tracy R
AU - Pell, Jill P
PY - 2022/10/12
Y1 - 2022/10/12
N2 - With increasing numbers infected by SARS-CoV-2, understanding long-COVID is essential to inform health and social care support. A Scottish population cohort of 33,281 laboratory-confirmed SARS-CoV-2 infections and 62,957 never-infected individuals were followed-up via 6, 12 and 18-month questionnaires and linkage to hospitalization and death records. Of the 31,486 symptomatic infections,1,856 (6%) had not recovered and 13,350 (42%) only partially. No recovery was associated with hospitalized infection, age, female sex, deprivation, respiratory disease, depression and multimorbidity. Previous symptomatic infection was associated with poorer quality of life, impairment across all daily activities and 24 persistent symptoms including breathlessness (OR 3.43, 95% CI 3.29-3.58), palpitations (OR 2.51, OR 2.36-2.66), chest pain (OR 2.09, 95% CI 1.96-2.23), and confusion (OR 2.92, 95% CI 2.78-3.07). Asymptomatic infection was not associated with adverse outcomes. Vaccination was associated with reduced risk of seven symptoms. Here we describe the nature of long-COVID and the factors associated with it.
AB - With increasing numbers infected by SARS-CoV-2, understanding long-COVID is essential to inform health and social care support. A Scottish population cohort of 33,281 laboratory-confirmed SARS-CoV-2 infections and 62,957 never-infected individuals were followed-up via 6, 12 and 18-month questionnaires and linkage to hospitalization and death records. Of the 31,486 symptomatic infections,1,856 (6%) had not recovered and 13,350 (42%) only partially. No recovery was associated with hospitalized infection, age, female sex, deprivation, respiratory disease, depression and multimorbidity. Previous symptomatic infection was associated with poorer quality of life, impairment across all daily activities and 24 persistent symptoms including breathlessness (OR 3.43, 95% CI 3.29-3.58), palpitations (OR 2.51, OR 2.36-2.66), chest pain (OR 2.09, 95% CI 1.96-2.23), and confusion (OR 2.92, 95% CI 2.78-3.07). Asymptomatic infection was not associated with adverse outcomes. Vaccination was associated with reduced risk of seven symptoms. Here we describe the nature of long-COVID and the factors associated with it.
KW - COVID-19/complications
KW - Female
KW - Hospitalization
KW - Humans
KW - Quality of Life
KW - SARS-CoV-2
KW - Post-Acute COVID-19 Syndrome
U2 - 10.1038/s41467-022-33415-5
DO - 10.1038/s41467-022-33415-5
M3 - Article
C2 - 36224173
VL - 13
JO - Nature Communications
JF - Nature Communications
SN - 2041-1723
M1 - 5663
ER -